126 related articles for article (PubMed ID: 10862636)
1. Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy.
Roccatello D; Mengozzi G; Gigliola G; Rossi D; Mosso R; Cacace G; Polloni R; Cesano G; Picciotto G; Paradisi L; Bancale E; Piccoli G; Sena LM
Nephrol Dial Transplant; 2000 Jul; 15(7):988-93. PubMed ID: 10862636
[TBL] [Abstract][Full Text] [Related]
2. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
[TBL] [Abstract][Full Text] [Related]
3. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Vervoort G; Hertenberg F; Wetzels JF; Smits P
J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
[TBL] [Abstract][Full Text] [Related]
5. Dual blockade of the renin-angiotensin-aldosterone system is safe and effective in reducing albuminuria in Asian type 2 diabetic patients with nephropathy.
Tan F; Mukherjee JJ; Lee KO; Lim P; Liew CF
Singapore Med J; 2010 Feb; 51(2):151-6. PubMed ID: 20358155
[TBL] [Abstract][Full Text] [Related]
6. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
Russo D; Minutolo R; Pisani A; Esposito R; Signoriello G; Andreucci M; Balletta MM
Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176
[TBL] [Abstract][Full Text] [Related]
7. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M; Tylicki L; Rutkowski P; Rutkowski B
Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
[TBL] [Abstract][Full Text] [Related]
8. The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.
Donmez G; Derici U; Erbas D; Arinsoy T; Onk A; Sindel S; Hasanoglu E
Jpn J Physiol; 2002 Oct; 52(5):435-40. PubMed ID: 12533248
[TBL] [Abstract][Full Text] [Related]
9. Isosorbide 5 mononitrate administration increases nitric oxide blood levels and reduces proteinuria in IgA glomerulonephritis patients with abnormal urinary endothelin/cyclic GMP ratio.
Roccatello D; Mengozzi G; Ferro M; Cesano G; Polloni R; Mosso R; Bonetti G; Inconis T; Paradisi L; Sena LM
Clin Nephrol; 1995 Sep; 44(3):163-9. PubMed ID: 8556832
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
Peters H; Border WA; Noble NA
Kidney Int; 2000 Apr; 57(4):1493-501. PubMed ID: 10760085
[TBL] [Abstract][Full Text] [Related]
12. IgA nephropathy and inhibitors of the renin angiotensin system: is reduction in proteinuria adequate proof of efficacy?
Reddan DN; Owen WF
Am J Kidney Dis; 2001 Jul; 38(1):182-5. PubMed ID: 11431200
[No Abstract] [Full Text] [Related]
13. [Effect of isosorbide mononitrate on hypotensive action of enalapril in patients with mild and moderate hypertension].
Przewłocka-Kosmala M
Pol Merkur Lekarski; 2002 Jul; 13(73):40-2. PubMed ID: 12362504
[TBL] [Abstract][Full Text] [Related]
14. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
15. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Mauer M; Zinman B; Gardiner R; Suissa S; Sinaiko A; Strand T; Drummond K; Donnelly S; Goodyer P; Gubler MC; Klein R
N Engl J Med; 2009 Jul; 361(1):40-51. PubMed ID: 19571282
[TBL] [Abstract][Full Text] [Related]
16. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
Horita Y; Tadokoro M; Taura K; Suyama N; Taguchi T; Miyazaki M; Kohno S
Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
[TBL] [Abstract][Full Text] [Related]
17. Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis.
Hutchinson FN; Webster SK
Am J Physiol; 1992 Aug; 263(2 Pt 2):F311-8. PubMed ID: 1510124
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Konno Y; Tsuruga K; Ito E; Waga S
Pediatr Int; 2004 Oct; 46(5):576-9. PubMed ID: 15491387
[TBL] [Abstract][Full Text] [Related]
19. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
Jilma B; Li-Saw-Hee FL; Wagner OF; Beevers DG; Lip GY
Clin Sci (Lond); 2002 Aug; 103(2):131-6. PubMed ID: 12149103
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy.
Remuzzi A; Perico N; Sangalli F; Vendramin G; Moriggi M; Ruggenenti P; Remuzzi G
Am J Physiol; 1999 Mar; 276(3):F457-66. PubMed ID: 10070170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
